How are CYP2C19 and Schlaf related?

CYP2C19 is a liver enzyme that metabolizes many drugs, including some used for sleep disorders (e.g., certain benzodiazepines, antidepressants). Genetic variants in CYP2C19 can alter how quickly these drugs are processed, potentially affecting their efficacy and side effects. However, a direct link between CYP2C19 variants and sleep quality or insomnia independent of medication is not well established. MyBody-X likely includes CYP2C19 in its pharmacogenetic (PGx) panel, not as a sleep-specific marker. The evidence is moderate for drug response but weak for a standalone effect on sleep. For sleep issues, consult a healthcare professional; genetics is only one factor.